Pacira | 销售和管理费用



Selling And Administration Expenses 更改 日
Astellas Pharma JPY 225.3B 25.77B 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
J&J USD 5.11B 1.34B 2025-03
Ligand Pharmaceuticals USD 25.6M 1.13M 2024-12
Novo Nordisk 16.59B 501M 2024-09
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12
Zoetis USD 625M 60M 2024-12



Pacira 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.